Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
₹ 272000 / 3200 Shares Shares
Minimum Investment
Invicta Diagnostic Limited IPO
Issues Price
₹80-85 per equity share
Invicta Diagnostic Limited IPO
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Lot Size
1600
Min. Investment
₹ 272000
Issue Price
₹80-85
Listing Date
08 Dec 2025
Issues Size
33,08,800 shares(aggregating up to ₹28.12 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
3200 Shares
Offered To Public
3200 Shares
Invicta Diagnostic Limited IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Founded In
2021
Managing Director
Dr. Ketan Jayantilal Jain
Parent Organization
Invicta Diagnostic Limited IPO
Application for Invicta Diagnostic Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹80-85 | ₹2,72,000 |
| Individual(max) | ₹80-85 | ₹2,72,000 |
| SHNI(min) | ₹80-85 | ₹4,08,000 |
| SHNI(max) | ₹80-85 | ₹9,52,000 |
| BHNI(min) | ₹80-85 | ₹10,88,000 |
Apply for all eligible candidates, Invicta Diagnostic Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
I was amazed by how quickly KSquare approved my loan. The entire system felt modern and very intuitive.
KSquare’s SIP plans align perfectly with my monthly savings goals. I appreciate how effortless the process is. It's really helped me become financially disciplined.
KSquare’s platform helped me diversify and start SIPs in mutual funds that really suit my lifestyle. I love how easy and intuitive everything feels.
With KSquare’s help, I finally understood the benefits of NPS. Their team is responsive and really knows their stuff.
I feel empowered thanks to KSquare. Their NRI Corner is well-structured, and the financial advice is incredibly relevant and actionable.
KSquare really simplified the NPS process for me. I appreciate their educational approach and helpful customer support.
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
KSquare helped me understand what to expect from each NFO. Their breakdown of fund strategy and goals made my investment decision very easy.
KSquare’s NRI Corner made investing from abroad incredibly simple. The guidance was crystal clear, and their support team always kept me informed. Highly recommend this service for all NRIs!
I started SIPs for my daughter’s education through KSquare, and the structured savings plan has given me peace of mind. Their transparent approach keeps my progress always clear and motivating.
FAQ's
Frequenlty Asked Question
Can I nominate someone in India for my investments?
Yes, NRIs can nominate any Indian resident for their mutual fund holdings and other financial assets via KSquare.
What are Tier I and Tier II NPS accounts?
Tier I is the mandatory retirement account with tax benefits, while Tier II is voluntary with flexible withdrawals but no tax deductions.
Can I switch between mutual funds on KSquare?
Yes, you can easily switch between funds on the KSquare platform based on your strategy or market movements.
What happens if I stop my SIP before maturity?
You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.
Are there any charges for managing NPS?
Yes, nominal charges apply for account maintenance and fund management, but they are among the lowest in the industry.
What documentation is needed to invest via KSquare?
You’ll need a valid passport, visa, PAN card, overseas address proof, and NRE/NRO bank details.
Can NRIs get a loan against mutual funds with KSquare?
Some lenders allow NRIs to avail loans. KSquare helps identify NRI-eligible lenders and assists with documentation.
Can I invest in SIPs from abroad with KSquare?
Yes, NRIs can set up SIPs through their NRE/NRO accounts. KSquare automates the process for convenience.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.